Overview
Status
Active
Registry date
2018-12-12
Share capital
5,000.00 PLN
Registered address
ul. Twarda 18, 00-105 Warszawa, Poland
Financials
Revenue history (in k)
From the notes
| Current income tax (CIT due) | $1,189 |
Filing timeliness
5 of 6 financial statements were filed late (the longest delay 1254 days for 2021).
- 202529/07/2026
- 202419/12/2025
- 202320/12/2025
- 202220/12/2025
- 202120/12/2025
- 202001/10/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Division · Manufacture of basic pharmaceutical products and pharmaceutical preparations180 / 231
Top 78%
Results vs industry
Revenue
This companyUSD 72.28kMedianUSD 919.05kAverageUSD 25.83m
Net profit
This companyUSD 8.96kMedianUSD 14.92kAverageUSD 2.77m
Operating costs
This companyUSD 56.20kMedianUSD 873.06kAverageUSD 21.43m
Assets
This companyUSD 50.24kMedianUSD 897.46kAverageUSD 31.52m
Industry
Authorized Representatives
Hewa Hamadameen Hama – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Hewa Abdullah Hamadameen Hamaage 40 | 50 | $675.31 | 50% |
Soran Ali Othman | 50 | $675.31 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2020-07-11.
15 1090 1014 0000 0001 4454 8481
34 1090 1014 0000 0001 4454 8333
92 1090 1056 0000 0001 4656 1703
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Anpharm Przedsiębiorstwo FarmaceutyczneS.A. | $111,469,394.21 | anpharm.pl | ||
| Tarchomińskie Zakłady Farmaceutyczne PolfaS.A. | $102,988,448.02 | polfa-tarchomin.com.pl | ||
| VercoS.A. | $43,577,172.02 | verco.com.pl | ||
| MedicofarmaS.A. | $8,530,473.72 | medicofarma.pl | ||
| VitamaS.A. | $4,287,087.38 | vitama.pl | ||
| Munar PharmaS.A. | $85,649.72 | munar.pl | ||
| Sanford Biotechsp. z o.o. | $2,586.64 | sanfordbiotech.com | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl | ||
| Auxilius PharmaS.A. | $0.83 | auxiliuspharma.com | ||
| Stg25Branch (foreign co.) | – | glagolica.eu |
Change history
| Date | Event | |
|---|---|---|
| 2023-02-06 | PKD change (Added: 10.89.Z, 20.42.Z, 70.22.Z) | |
| 2023-01-11 | Address change (Ul. Chmielna 132/134, 00-805, Warszawa → Ul. Twarda 18, 00-105, Warszawa) | |
| 2020-10-27 | Address change (Plac Bankowy 2, 00-095, Warszawa → Ul. Chmielna 132/134, 00-805, Warszawa) | |
| 2019-07-12 | Address change (Aleja Jana Pawła Ii 27, 00-867, Warszawa → Plac Bankowy 2, 00-095, Warszawa) | |
| 2019-07-12 | Name change (Machers → Oriofarm) |
FAQ
The main business activity of Oriofarm focuses on manufacture of pharmaceutical preparations.
The company was registered in the Polish National Court Register (KRS) on December 12, 2018.
The headquarters is located at: ul. Twarda 18, 00-105 Warszawa.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
In 2025, the company generated total revenue of $72,282, representing a decrease of 20.5% compared to 2024.
Yes, the company recorded a net profit of $8,962 in 2025, meaning the company decreased its profit by 54.6%.
The largest operating cost category falls under cost of goods and materials sold. This category amounted to $38,680 in 2025, representing 69% of all operating expenses.
Last updated: 2026-07-29